| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 11/17/2010 | EP2250887A2 Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins |
| 11/17/2010 | EP2250185A1 Novel lupane derivatives |
| 11/17/2010 | EP2249868A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 11/17/2010 | EP2249867A2 Composition for the treatment of oxidative stress |
| 11/17/2010 | EP2249866A2 Use of an acetylsalicylic acid salt for the treatment of viral infections |
| 11/17/2010 | EP2249861A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 11/17/2010 | EP2249854A1 Improved treatment and prophylaxis |
| 11/17/2010 | EP2249848A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 11/17/2010 | EP2249836A1 Fluoroquinolone derivatives for ophthalmic applications |
| 11/17/2010 | EP2249831A2 Methods of using (+)-1,4-dihydro-7-ý(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl¨-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 11/17/2010 | EP2249820A1 Trpa1 antagonists |
| 11/17/2010 | EP2249805A1 Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 11/17/2010 | EP1996014B1 Composition for treating bacterial, viral, fungal diseases, inflammation and pain |
| 11/17/2010 | EP1599194B1 Use of acetylsalicylic acid for the prophylaxis and/or therapy of viral diseases |
| 11/17/2010 | EP1565489B1 Internalizing antibodies specific for the RAAG10 cell surface target |
| 11/17/2010 | EP1545597B1 Immunostimulatory compositions and methods of stimulating an immune response |
| 11/17/2010 | EP1480616B1 Aerosol formulations of diisobutyryl apomorphine |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | CN1927400B Biomagnetism nano target anti-cancer drug and its preparation |
| 11/17/2010 | CN101884790A Medicament for treating cervical ossified posterior longitudinal ligament |
| 11/17/2010 | CN101884789A Ctgf as target for the therapy of diabetic nephropathy |
| 11/17/2010 | CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 11/17/2010 | CN101884780A Use of hepcidin as a regulator of iron homeostasis |
| 11/16/2010 | US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation |
| 11/16/2010 | US7834054 Hydroxamates as therapeutic agents |
| 11/16/2010 | US7834053 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator |
| 11/16/2010 | US7834049 Integrin expression inhibitor |
| 11/16/2010 | US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases |
| 11/16/2010 | US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 11/16/2010 | US7833973 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions |
| 11/16/2010 | US7833722 Ligands for G protein-coupled receptor protein and use thereof |
| 11/16/2010 | US7833551 biosynthesis inhibition via formaldehyde, glutaraldehyde, acrolein, quaternary amine compounds, cocodiamine, bronopol, 2-2-dibromo-3-nitrilo-propionamide; synergistic; cost efficiency |
| 11/16/2010 | US7833545 Methods and devices for the sustained release of multiple drugs |
| 11/16/2010 | US7833542 Method and composition for the treatment of scars |
| 11/16/2010 | US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies |
| 11/16/2010 | CA2510655C Uses of adenosine a2a receptor antagonists |
| 11/16/2010 | CA2479084C Vdac regulator |
| 11/16/2010 | CA2477109C System for transvaginal drug delivery |
| 11/16/2010 | CA2452114C Tgf-.beta. superfamily production/secretion promoter |
| 11/16/2010 | CA2415643C Pharmaceutical composition for oral use with improved absorption |
| 11/16/2010 | CA2405479C Method of inhibiting the expression of inflammatory cytokines and chemokines |
| 11/16/2010 | CA2398901C Methods and compositions for treating conditions of the eye |
| 11/16/2010 | CA2367240C Treatment of accidental extravasation of anthracyclines |
| 11/16/2010 | CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions |
| 11/16/2010 | CA2261334C Bovine polynucleotide vaccine for the intradermal route |
| 11/11/2010 | WO2010129710A1 Use of rankl to induce differentiation of microfold cells (m cells) |
| 11/11/2010 | WO2010128873A1 Combination of an opioid analgesic and an n-type calcium channel blocker for treating chronic pain |
| 11/11/2010 | WO2010128309A1 Combination therapy comprising a taxane and a sigma receptor ligand sauch as rimcazole |
| 11/11/2010 | WO2010042886A3 Pyrones for the treatment of metabolic disorders |
| 11/11/2010 | WO2009105256A3 Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand |
| 11/11/2010 | US20100286375 Carrier molecules |
| 11/11/2010 | US20100286256 Compositions and methods for therapy for diseases characterized by defective chloride transport |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285089 Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon |
| 11/11/2010 | US20100285044 Method and compositions for treatment of cancers |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 11/11/2010 | US20100284980 Nutritional Composition To Promote Healthy Development And Growth |
| 11/11/2010 | DE102009018133A1 Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen A pharmaceutical composition for the treatment of dermatological autoimmune diseases |
| 11/10/2010 | EP2248829A1 Treatment with anti-VEGF antibodies |
| 11/10/2010 | EP2248828A1 Method for treating inflammation |
| 11/10/2010 | EP2248808A1 Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
| 11/10/2010 | EP2248537A1 Restoration of cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 11/10/2010 | EP2248523A1 Compounds for use in the treatment of clinical conditions resulting from a deficit of endothelial progenitor cells |
| 11/10/2010 | EP2247287A2 Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients |
| 11/10/2010 | EP2018169B1 Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| 11/10/2010 | EP1603595B1 Pharmaceutical composition for treatment of drug dependence |
| 11/10/2010 | EP1569692B1 Betaine and salicylic acid compositions |
| 11/10/2010 | EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 11/10/2010 | EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases |
| 11/10/2010 | EP1265915B1 Novel compounds |
| 11/10/2010 | EP1153613B1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism |
| 11/10/2010 | CN1874781B Compositions of botanical extracts for cancer therapy |
| 11/10/2010 | CN1861041B Temp-sensitive, slow-releasing gel used for local injection, and its preparation method |
| 11/10/2010 | CN1747741B Composition for treatment and prevention of inflammatory bowel disease and its uses |
| 11/10/2010 | CN1705494B Colon cleansing compositions |
| 11/10/2010 | CN1561208B Methods to mobilize progenitor/stem cells |
| 11/10/2010 | CN101883590A Method of treating hepatitis C patients |
| 11/10/2010 | CN101883589A Pharmaceutical compositon for cleansing of the bowel |
| 11/10/2010 | CN101883566A Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 11/10/2010 | CN101883561A New therapeutic approaches for treating Charcot-Marie-Tooth disease |
| 11/10/2010 | CN101880387A Delivery vector with surface-etched polymer and pharmaceutical composition |
| 11/10/2010 | CN101880283A Azaindole kinase inhibitors |
| 11/10/2010 | CN101879315A Polymalic acid prodrug derivant and applications thereof |
| 11/10/2010 | CN101879166A Carbostyril derivative and serotonin reuptake inhibitor for treating patients with mood disorders |
| 11/10/2010 | CN101879140A Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds |
| 11/10/2010 | CN101417131B External medicine combination for treating skin allergic disease |
| 11/10/2010 | CN101352425B Compound osmotic pump controlled release preparation and preparation method thereof |
| 11/10/2010 | CN101337071B Composition for preparing anti-cataract products |
| 11/10/2010 | CN101198355B Agent for prevention or treatment of glaucoma |
| 11/10/2010 | CN101180062B Compound preparation for treating diabetes mellitus |
| 11/09/2010 | US7829675 TWEAK receptor |
| 11/09/2010 | US7829672 Modulation of sodium channels in dorsal root ganglia |
| 11/09/2010 | US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia |
| 11/09/2010 | US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents |
| 11/09/2010 | US7829555 noncytotoxic bioreductive drug conjugates, used for targeting a therapeutic agent to a site of hypoxia and/or ischemia within the human or non-human animal body, suitable for the treatment of arthritis, diabetes, atherosclerosis, stroke, sepsis, cancer, Alzheimer's, kidney, digestive or liver disease |
| 11/09/2010 | US7829549 Methods for treating bleeding disorders using sulfated polysaccharides |
| 11/09/2010 | US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds |